Granules India has received U.S. Food and Drug Administration approval for Lisdexamfetamine Dimesylate chewable tablets, its generic version of Takeda Pharmaceuticals’ central nervous system ...

Granules India Limited, a vertically integrated Indian pharmaceutical company, announced that its wholly-owned foreign subsidiary, Granules Pharmaceuticals, Inc. (GPI), has received approval from the ...

Granules India Confident in USFDA Compliance, Focuses on New Products - Granules India , a Hyderabad-based pharmaceutical ...

On the first-day share sale process, the IPO was fully subscribed within minutes and closed with a 13.32 times subscription.

Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI ...